Previous Article | Next Article ![]()
Infection and Immunity, February 2002, p. 535-543, Vol. 70, No. 2
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.70.2.535-543.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Departments of Microbiology,1 Departments of Pathology, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, Tennessee 37614-0579,2 Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599-72903
Received 2 July 2001/ Returned for modification 6 September 2001/ Accepted 24 October 2001
|
|
|---|
|
|
|---|
Although many devoted investigators have provided key insights into how chlamydiae initiate infection, there is much that remains to be determined concerning the multifactorial processes used by EB to gain access to their intracellular habitat in susceptible host cells. No singular chlamydial component has been identified as a high-affinity surface ligand. The lack of a prominent adhesin is consistent with observations that chlamydiae enter host cells by multiple routes (39). Closely related chlamydial biovariants exhibit clear differences in the utilization of known adherence mechanisms, which is thought to reflect properties inherent in tissue tropism and directional spread of infection (10).
Several years ago, study findings demonstrated that the chlamydial 70-kDa heat shock protein (Hsp70) (38) and the cochaperone protein GrpE (44) are associated with isolated outer membrane complexes of Chlamydia trachomatis. Moreover, when these proteins were expressed in recombinant Escherichia coli, the recombinant attached to human endometrial epithelial cells in a manner mimicking that observed for C. trachomatis EB (43). As determined by electron microscopy, the adherent recombinant appeared to be anchored in clathrin-coated pits. Also similar to chlamydial EB, the recombinant E. coli exhibited increased adherence to estrogen-dominant primary endometrial epithelial cells and decreased adherence to progesterone-dominant primary endometrial epithelial cells (31, 43). These surprising observations prompted further investigation of the contribution of chlamydial Hsp70 to attachment to human genital epithelial cells.
In this study, antibodies were generated against three peptides representing different domains of C. trachomatis serovar E Hsp70, and these antibodies were used to investigate exposure of Hsp70 at the surface of purified EB. Although none of the domains was prominently displayed at the surface, the Hsp70 substrate-binding domain became selectively accessible following brief reduction of the cysteine-rich outer membrane protein lattice with the reducing reagent dithiothreitol (DTT). A thiol-alkylating reagent, 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB), was subsequently used to determine whether reduction of EB membrane proteins occurs at the surface of the host cell just prior to or during EB entry. DTNB is a membrane-impermeable reagent that covalently modifies surface sulfhydryls to prevent disulfide bond cleavage (41) and has been used to demonstrate that the rigid, disulfide-cross-linked proteins in the envelope of Sindbis virus are modified by host surface reductase activities for efficient viral penetration (1). In the present study, chlamydial infectivity, but not attachment, was compromised by DTNB, which suggests that reduction of EB disulfide-cross-linked envelope proteins occurs in the microenvironment of the host cell surface. This reductive event, in turn, exposes the chlamydial Hsp70 substrate-binding domain. Overall, our data indicate that chlamydial Hsp70 is not a primary, surface-displayed ligand and that although substrates for envelope-associated Hsp70 are not known yet, the role of Hsp70 in adherence may be to provide a more intimate interaction with host ligands following the initial stages of attachment. Alternatively, Hsp70 may assist in the conformation and presentation of other chlamydial adhesins during attachment and entry.
|
|
|---|
The methods used to grow recombinant E. coli JM109(pPBW58) and the characteristics of this strain have been described elsewhere (38, 43, 44). Purified recombinant chlamydial Hsp70 used for proteolytic mapping was obtained from E. coli LMG194(pPBW120). The open reading frame encoding Hsp70 was amplified from the C. trachomatis serovar E genome by using the Expand High Fidelity PCR system (Boehringer Mannheim) and 5'-GGCGGTACCTTACTCAGGTTTATCAACAATTTCAACATCAGC-3' and 5'-CGCCTCGAGATGAGCGAAAAAAGAAAGTCTAACAAAATTATTGG-3' as the forward and reverse primers, respectively. The 1,983-kb product was ligated into the multiple cloning site of pBAD/HisA (Invitrogen Corp.) and was verified by sequencing. Chlamydial Hsp70 was overexpressed by inducing E. coli LMG194(pPBW120) with 0.002% (vol/vol) L-arabinose, and histidine-tagged Hsp70 was purified by nickel affinity chromatography by using the manufacturers instructions (Invitrogen Corp.).
Preparation of antibodies, protein analyses, and immunoblotting. Monospecific polyclonal antibodies against three custom-designed 18-amino-acid peptides in the C. trachomatis serovar E Hsp70 sequence were generated in New Zealand White female rabbits by GenoSys Biotechnologies Inc.; preimmune serum from each rabbit was also provided. Enzyme immunoassays to determine the peptide reactivities of all antisera, as well as a double-diffusion agarose precipitation assay against keyhole limpet hemocyanin, were conducted by GenoSys as part of their quality control. After arrival in our laboratory, the immunoglobulin G (IgG) fraction of each serum was purified with protein G affinity matrices (Pharmacia LKB) by using 20 mM sodium phosphate (pH 7.0) as the running buffer. IgG was eluted in 0.1 M glycine-hydrochloric acid (pH 2.7) buffer, immediately neutralized with 1 M Tris-HCl (pH 9.0), and dialyzed overnight at 4°C against 10 mM sodium phosphate buffer (pH 7.0). Aliquots were subsequently stored at -20°C.
The total protein contents of all samples in this study were determined by the bicinchoninic acid microassay (Pierce Chemical Co.), using bovine serum albumin as the standard. The stock concentrations of IgG preparations were adjusted to 1 µg of total protein per µl before the preparations were diluted for all immunoassays. Purified C. trachomatis serovar E EB, as well as mid-logarithmic-growth-phase E. coli JM109(pUC19), JM109(pPBW58), and LMG194 (pPBW120), were washed by repetitive centrifugation and resuspended in phosphate-buffered saline (PBS) (pH 7.0) prior to protein analyses. Proteins were solubilized, resolved by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) by using 12.5% polyacrylamide separation gels, and visualized by staining with silver or Coomassie blue or by Western blotting as described previously (38), using a 1:1,000 (vol/vol) dilution for each IgG preparation. A 1:2,500 (vol/vol) dilution of goat anti-rabbit alkaline phosphatase-conjugated antibodies was used for detection.
Partial proteolytic digests of affinity-purified chlamydial Hsp70 were obtained by incubating 66.0 µg of Hsp70 with 0.5 µg of endoproteinase Arg-C (Promega) for 30 s at 37°C (protein/protease ratio, 132:1). Proteolytic activity was stopped by adding 1 µM EDTA, and samples were resolved by SDS-PAGE prior to Western blot analysis; approximately 13.0 µg of total protein was loaded into each lane.
Immunoprecipitation. To confirm that peptide antisera reacted with nondenatured Hsp70, cultures of E. coli JM109(pUC19) and JM109(pPBW58) were washed twice in Tris-buffered saline (TBS) (50 mM Tris-HCl [pH 7.4], 150 mM NaCl). Approximately 1 x 107 CFU of each sample per ml was suspended in cold (4°C) TBS containing 1% (vol/vol) Triton X-100, placed in a water bath sonicator, and sonicated intermittently over a 20-min period; samples were placed on ice between pulses. Each resultant lysate was cleared by centrifugation at 13,000 x g for 45 min at 4°C and incubated for 1 h with 50 µl of protein A-Sepharose (Pharmacia LKB) to reduce nonspecific binding. Cleared supernatants were subsequently divided into multiple 100-µl aliquots, 10 µg of each IgG preparation was added to an aliquot, and the aliquots were incubated overnight on a rocking platform at 4°C. Fifty microliters of protein A-Sepharose was then added to each sample, the preparation was incubated for 2 h, and beads were gently pelleted and washed three times with Triton X-100-TBS and once with TBS alone prior to solubilization and resolution by SDS-PAGE. The immunoprecipitated protein was confirmed to be Hsp70 by Western blotting by using a monospecific chlamydial Hsp70 antibody (38).
Attachment and neutralization assays. Metabolically 35S-radiolabeled EB preparations were used to assess attachment to HEC-1B host cells, whereas nonlabeled EB preparations were used to determine neutralization of chlamydial infectivity by staining intracellular inclusions with a pool of fluorescein-conjugated monoclonal antibodies generated against the C. trachomatis MOMP (Syva) (10). All experiments were conducted at least three times, and each sample was assayed in triplicate or quadruplicate. Statistical significance was determined by using a two-tailed Students t test.
For attachment, 35S-labeled EB were suspended in diluent (a 1:1 [vol/vol] mixture of storage buffer and Dulbeccos modified Eagle medium without fetal calf serum) and inoculated onto nearly confluent monolayers of HEC-1B cells that had been washed once with PBS. After 1 h, host cells with adherent EB were washed three times with cold PBS and solubilized in 2% (vol/vol) SDS prior to immersion in scintillation cocktail. Radioactive counts were obtained for adherent EB as well as nonadherent EB in the supernatants and the washes; the data were expressed as percentages of the EB population that bound to HEC-1B cells.
For neutralization of chlamydial infectivity by various antibodies, 10 or 100 µg of total IgG per ml was added to 50-µl aliquots of EB; samples with no antibodies served as controls. After inoculation and incubation, the number of infected cells was determined at 48 h by staining for inclusions; at least 30 microscopic fields per sample were examined. To determine whether antibodies interacted with the host cell membrane, uninfected HEC-1B cells were incubated with 100 µg of each antibody per ml, incubated with fluorescein-conjugated anti-rabbit whole IgG, counterstained with Evans blue, and examined by fluorescence microscopy.
The effect of the reducing agent DTT on chlamydial attachment was examined by exposing purified 35S-labeled EB to 20 mM DTT in PBS for 2, 5, 10, or 30 min at 25°C or by incubating 35S-labeled EB in PBS alone as a control; samples were processed and counted as described above. Nonradiolabeled EB were used to assess inhibition of chlamydial infectivity by DTT. Four conditions were used to investigate the role of DTNB (final concentration, 2.5 mM) on both chlamydial attachment and neutralization. These conditions included (i) exposure of EB to DTNB in diluent for 30 min at 35°C, followed by removal of the DTNB by centrifugation, resuspension of the exposed EB in diluent, and inoculation of HEC-1B cells with the EB; (ii) exposure of HEC-1B cell monolayers to DTNB in diluent for 30 min at 35°C, followed by one wash with PBS prior to inoculation with EB; (iii) addition of DTNB to the EB inoculum during the 1-h adsorption period; and (iv) addition of DTNB 30 min after EB inoculation. Importantly, a 1-h exposure to 5.0 mM DTNB was not cytotoxic for HEC-1B cells (LIVE/DEAD viability/cytotoxicity kit; Molecular Probes, Inc.).
Immunofluorescence and electron microscopy. An immunofluorescence assay was developed to examine the reactivities of antisera with the surfaces of EB. Purified EB were pelleted by centrifugation and resuspended in sterile water to a concentration of 1,000 EB per 10 µl; then 10-µl drops were placed in 6-mm wells on an eight-well microscope slide and allowed to air dry for 10 min. Fifty-micoliter drops of PBS, with or without 20 mM DTT, were placed on the EB for 15 min at 25°C. This was followed by one wash with PBS, and then primary antisera (1:50 [vol/vol] dilutions in PBS) were added to the EB and the preparations were incubated for 1 h at 37°C. After removal of the primary antisera and three washes with PBS, a 1:300 (vol/vol) dilution of fluorescein isothiocyanate-conjugated goat anti-rabbit IgG (Sigma Chemical Co.) in PBS was added to the EB, and the preparations were incubated for 1 h at 37°C. After final washes with PBS, samples were covered with polyvinyl alcohol mounting medium (Sigma Chemical Co.) and examined with a Zeiss Axiovert 10 microscope at a magnification of x40. Images of fluorescent EB were recorded by computer-aided morphometry (Metamorph; Universal Imaging Corp.). A pool of fluorescein-labeled MOMP antibodies (Syva) and polyclonal antisera against whole C. trachomatis serovar E EB (43) served as positive controls for EB surface labeling; the EB particles in at least six microscopic fields per sample were counted. A monospecific polyclonal antibody against the chlamydial histone 2 protein (17) was used as an internal control to verify that DTT exposure did not result in lysis of the EB.
For transmission electron microscopic analyses, purified EB were suspended in PBS with or without 20 mM DTT and incubated for 15 min at 25°C. The EB were subsequently placed on Formvar-coated gold grids (300 mesh) and immunolabeled by inverting the grids over drops of each peptide antibody reagent (1:50, vol/vol) and incubating them for 1 h at 37°C. After washing in PBS and incubation with a secondary 30-nm gold-conjugated goat anti-rabbit detection antibody, the samples were washed in distilled water and negatively stained for 15 s with 1% (wt/vol) phosphotungstic acid (pH 7.0). Samples were examined with a Zeiss EM900 transmission electron microscope operating at 50 kV.
Assembly of data. Fluorescent images analyzed by the Metamorph imaging software were exported into Adobe Photoshop 5.0 as PICT or TIFF files for assembly of composite figures. All additional gels, Western blots, and negatives obtained from the electron microscope were recorded with a Microtek ScanMaker III and assembled by using Adobe Photoshop 5.0 and Adobe Pagemaker 6.0 software for the Power Macintosh.
|
|
|---|
![]() View larger version (27K): [in a new window] |
FIG. 1. Description of C. trachomatis serovar E Hsp70 synthetic peptides. Three 18-amino-acid peptides (A) (solid boxes) at different locales in the chlamydial Hsp70 protein were used as immunogens to generate monospecific polyclonal antibodies. Each peptide sequence (B) (numbers indicate amino acid residues) was chosen based on specific, documented features of the region, as well as predictive protein modeling. The numbers in parentheses are reference numbers.
|
![]() View larger version (54K): [in a new window] |
FIG. 2. Western blot reactivity of chlamydial Hsp70 peptide antibodies with C. trachomatis serovar E EB proteins. Total EB protein was separated by SDS-PAGE, and the resultant profile was visualized by staining with Coomassie blue (A). A Western blot analysis (B) was conducted with total EB protein transferred to nitrocellulose by incubating blots with either preimmune antibodies (lanes 1, 3, and 5) as a control or antibodies from rabbits immunized with synthetic peptides targeted against the chlamydial Hsp70 amino terminus (lane 2), the midregion (lane 4), and the carboxyl terminus (lane 6).
|
Because heat shock proteins are potent antigens, two assays were conducted to confirm that the immune response generated against each peptide was an immune response directed against the peptide instead of a response directed against whole Hsp70. First, an enzyme immunoassay in which anti-IgG horseradish peroxidase was used as a secondary detection antibody revealed that the peptide antiserum dilutions required to produce 1.0 U of optical density at 450 nm ranged from 1:3,000 to 1:50,000 (vol/vol) when the peptide antiserum was assayed against the appropriate peptide; the only reactivity observed for antisera against unmatched peptides was the reactivity due to antibodies against keyhole limpet hemocyanin, which was conjugated to the synthetic peptides prior to immunization (GenoSys Biotechnologies, Inc.) (data not shown). The second approach used revealed specific Hsp70 peptide reactivities by Western blotting of partial proteolytic digests of purified recombinant chlamydial Hsp70 (Fig. 3). Purified Hsp70 was partly digested with endoproteinase Arg-C to produce a ladder of Hsp70 peptide fragments (Fig. 3A, lane 2). A polyclonal antiserum generated against whole recombinant chlamydial Hsp70 (38) showed antigenic recognition, in almost stoichiometric proportions, of the major peptides in the proteolytic digest (compare Fig. 3A, lane 2, with Fig. 3B, lane 1). As expected, the immunoreactive profiles obtained with each peptide antiserum were unique and reflected considerable differences in recognition within the pool of proteolytic peptide fragments (Fig. 3B, lanes 2 to 4).
![]() View larger version (65K): [in a new window] |
FIG. 3. Reactivities of peptide antibodies with Hsp70 fragments generated by partial proteolytic digestion. (A) Affinity-purified chlamydial Hsp70 from E. coli LMG194(pPBW120) (lane 1) was partially digested with endoproteinase Arg-C (lane 2), and SDS-PAGE-resolved peptides were visualized by staining with Coomassie blue. Lane M contained molecular mass markers. (B) Western blotting of duplicate samples of the Hsp70 proteolytic digest to examine the antigenic reactivities of Hsp70 antisera generated against the entire protein (lane 1), the amino terminus peptide (lane 2), the midregion peptide (lane 3), and the carboxyl terminus peptide (lane 4).
|
![]() View larger version (88K): [in a new window] |
FIG. 4. Peptide antibodies interact with nondenatured chlamydial Hsp70. Triton X-100-soluble protein from recombinant E. coli was precipitated from solution by using Hsp70 peptide antibodies. (A) Following resolution by SDS-PAGE, 20-µg portions of total protein from E. coli JM109 (lane 1) and E. coli JM109(pPBW58) (lane 2) were visualized by staining with Coomassie blue. The arrow indicates the position of recombinant C. trachomatis serovar E Hsp70. Lane M contained molecular mass markers. (B to D) For immunoprecipitation, both preimmune antibodies (lanes 1 and 3) and peptide antibodies (lanes 2 and 4) were incubated with protein from E. coli JM109 (lanes 1 and 2) and E. coli JM109(pPBW58) (lanes 3 and 4). Peptide antibodies generated against the amino terminus (B), the midregion (C), and the carboxyl terminus (D) were all able to precipitate recombinant chlamydial Hsp70 from solution (lanes 4, arrows). Western blot data are shown in panels B to D; visualization of the total protein by silver staining produced identical results (data not shown).
|
![]() View larger version (54K): [in a new window] |
FIG. 5. C. trachomatis serovar E Hsp70 peptide antibodies do not neutralize chlamydial infectivity in vitro. Two concentrations (10 and 100 µg/ml) of preimmune IgG and anti-peptide IgG were added to C. trachomatis serovar E EB inocula prior to infection of HEC-1B epithelial cell monolayers. The numbers of intracellular chlamydial inclusions per x40 microscopic field were determined after infected cell monolayers were stained with a pool of fluorescein-conjugated monoclonal antibodies generated against the C. trachomatis MOMP. The control EB inoculum contained no added antibodies, whereas addition of IgG generated against whole C. trachomatis serovar E EB ( EB) served as a positive control for neutralization. This experiment was conducted on three separate occasions, and each sample was assayed in triplicate or quadruplicate (n = 9 to 12); the error bars indicate one standard deviation of the mean. An asterisk indicates that the P value was <0.01.
|
![]() View larger version (35K): [in a new window] |
FIG. 6. Surface accessibility of each chlamydial Hsp70 peptide domain on purified C. trachomatis serovar E EB as visualized by immunofluorescence microscopy. Purified C. trachomatis serovar E EB were incubated with polyclonal antisera generated against MOMP (A) and whole EB (B) as positive controls for surface labeling. EB either were not exposed (C, E, G, and I) or were exposed (D, F, H, and J) to 20 mM DTT and incubated with antisera generated against chlamydial histone protein 2 (His 2) as an internal control (C and D). The Hsp70 amino terminus peptide (N-term) (E and F), the midregion peptide (G and H), and the carboxyl terminus peptide (C-term) (I and J) were examined. Fluorescein isothiocyanate-conjugated goat anti-rabbit IgG served as a secondary detection antibody, and images were captured by computer-assisted morphometry.
|
![]() View larger version (91K): [in a new window] |
FIG. 7. Surface accessibility of each chlamydial Hsp70 peptide domain on purified C. trachomatis serovar E EB, as visualized by transmission electron microscopy. Chlamydial Hsp70 peptide antibodies against the amino terminus (A and D), the midregion (B and E), and the carboxyl terminus (C and F) were used to examine labeling of the EB surface by negative staining with phosphotungstic acid and electron microscopy. A goat anti-rabbit 30-nm gold-conjugated antiserum was used for detection (arrows). EB either were not exposed (A to C) or were exposed (D to F) to 20 mM DTT. (A) Magnification, x48,000; (B) x50,000; (C) x44,500; (D) x43,500; (E) x39,000; and (F) x41,500.
|
To examine the influence of DTNB on chlamydial infection, (i) purified EB were incubated for 30 min in the presence or absence of DTNB, (ii) HEC-1B cells were preexposed to DTNB for 30 min, or (iii) DTNB was added during inoculation of EB onto HEC-1B cells. The effect of DTNB on both EB attachment and infectivity (Fig. 8) was very similar to the effect reported previously in the virus study. DTNB did not interfere with EB attachment based on the experimental parameters examined. Indeed, preexposure of EB to DTNB resulted in a 20% increase in adherence of EB to HEC-1B cells (Fig. 8, lane 3), while chlamydial infectivity was reduced by 12%. Significant (P < 0.01) inhibition was observed when DTNB was present during the inoculation period. DTNB had no effect on either attachment or infectivity if it was added to infected HEC-1B cells 30 min postinoculation (data not shown), confirming that DTNB did not penetrate the host cell plasma membrane. In addition, no cytotoxicity toward HEC-1B cells was observed upon DTNB exposure. These data suggest that reduction of EB outer membrane protein disulfide bonds occurs prior to or during the entry process that leads to a productive chlamydial infection.
![]() View larger version (21K): [in a new window] |
FIG. 8. Effect of the thiol-alkylating reagent DTNB on C. trachomatis serovar E EB attachment to and infectivity in HEC-1B cells. C. trachomatis serovar E EB either were not exposed (bars 1) or were preexposed (bars 3) to 2.5 mM DTNB prior to inoculation onto HEC-1B cells to assess attachment and inhibition of inclusion formation. The samples used also included preparations in which HEC-1B cells were preexposed to 2.5 mM DTNB prior to inoculation with EB (bars 2) and preparations to which 2.5 mM DTNB was added during the inoculation period (bars 4). Attachment and infectivity assays were conducted as described in Materials and Methods. This experiment was conducted on three separate occasions, and each sample was assayed in triplicate or quadruplicate (n = 9 to 12); the error bars indicate one standard deviation of the mean. An asterisk indicates that the P value was <0.01.
|
![]() View larger version (23K): [in a new window] |
FIG. 9. Effect of preexposure of EB to 20 mM DTT on C. trachomatis serovar E EB attachment to and infectivity in HEC-1B cells. C. trachomatis serovar E EB were exposed to DTT for 2, 5, 10, or 30 min, washed, and examined for attachment to HEC-1B cells and inclusion formation as described in Materials and Methods. This experiment was conducted on three separate occasions, and each sample was assayed in triplicate or quadruplicate (n = 9 to 12); the error bars indicate one standard deviation of the mean.
|
|
|
|---|
The purpose of this study was to determine whether the chlamydial Hsp70 is displayed on the surface of EB, as would be expected for a primary adhesin. We examined three peptide regions at different locales in the C. trachomatis serovar E Hsp70 that, based on predictive modeling, were candidates for surface exposure. Our data show that each of the epitopes selected was only minimally exposed on purified EB. Interestingly, a brief incubation with the reducing reagent DTT led to selective surface exposure of the Hsp70 carboxyl terminus. It is well known that this Hsp70 domain mediates binding to other protein substrates and exhibits a preference for extended hydrophobic polypeptides (5). Whether the chlamydial Hsp70 is bound to another protein substrate, such as a separate chlamydial outer membrane protein, is not known.
The related issue addressed in this study is the status of the structural integrity of EB envelopes, relative to protein disulfide cross-linking, during EB attachment to and infection of human endometrial epithelial cells. Our most notable finding is that exposure of EB to the thiol-alkylating reagent DTNB inhibits chlamydial infectivity with no detrimental effect on attachment to host cells. This observation parallels the previously reported effects of DTNB on attachment and entry of Sindbis virus in eukaryotic host cells (1). Both EB and Sindbis virus are unique in terms of the extent of disulfide-cross-linked proteins in their envelopes; the envelopes are better described as rigid external matrices with associated lipids than as fluid lipid bilayers with associated proteins. Similar to the observations made with Sindbis virus, DTNB reduced but did not eliminate entry and infectivity of chlamydiae in host cells. The partial inhibition is attributed to the rapid rate of the thiol disulfide exchange reactions (once every 10-6 s) that occur within and between cysteine-containing polypeptides that are located close to each other (8); DTNB competes inefficiently for transiently exposed disulfide cross-links.
The greatest level of inhibition of chlamydial infectivity (30%) occurred if DTNB was present during the inoculation period, suggesting that disulfide bonds within the EB outer membrane protein complex become exposed during localized surface reduction. DTNB does not penetrate host cell plasma membranes. In a hallmark study, DTNB was shown to inhibit the host cell cytotoxicity of diphtheria toxin, which must be cleaved into A and B subunits at the surfaces of host cells; conversely, DTNB has no effect on the cytotoxicity of ricin toxin, which is cleaved into subunits only after internalization by host cells (41).
The source of reductase activity that elicits conformational changes in the EB envelope is not known. However, reductases are present at the surfaces of eukaryotic plasma membranes (13, 30). One leading candidate is a eukaryotic protein disulfide isomerase (PDI) that not only is present at the surfaces of host cells but also is required for optimal functioning of estrogen receptors (27). No host cell receptors have been conclusively defined for C. trachomatis EB, but it is notable that EB attach with greater avidity to estrogen-dominant primary endometrial epithelial cells than to progesterone-dominant cells (31). An alternative possibility is that chlamydial EB have an inherent reductase activity that might be stimulated by contact with the host cell surface.
Overall, the data presented in this report suggest that (i) the conformation of the EB envelope, maintained by protein disulfide cross-linking, is important during the primary stage of adherence, (ii) reduction of disulfide bonds occurs at the host cell surface, and (iii) reduction is necessary for efficient and productive EB entry and infectivity. Exposure of the chlamydial Hsp70 substrate-binding domain should occur after the primary stage of attachment but before or during EB entry. Therefore, the role of chlamydial Hsp70 may be to establish a more intimate interaction with host cell ligands rather than to serve as a primary adhesin. Alternatively, Hsp70 and cochaperones may direct conformational rearrangements among other EB outer membrane adhesin candidates (25, 26, 46, 48, 49, 50, 51) so that primary and/or secondary ligands are correctly presented for entry into susceptible target host cells. E. coli DnaK exhibits strong binding affinities for hydrophobic domains of integral outer membrane proteins and is thought to play a crucial role in the biogenesis and functionality of the envelope of this gram-negative organism (11).
Conformation-dependent interactions of Hsp70s with other protein substrates in a complex environment have been reported by several investigators (11, 12, 35, 40). We are not the first researchers to suggest that rearrangements occur within the envelope of EB during attachment to host cells; Su et al. (50) have shown that the MOMP undergoes conformational changes during the initial stages of infection. There is also evidence that adherence mediated by the 60-kDa cysteine-rich protein depends on conformation (51). Although the driving force behind these changes in chlamydial outer membrane proteins is not yet known, the chlamydial chaperones Hsp70, GrpE, and DnaJ are logical candidates. Chaperone-mediated conformational changes would require energy driven by ATP hydrolysis, and there is evidence for (i) inducible ATPase activity in EB (33), (ii) penetration of ATP via reduced MOMP (53), and (iii) inhibition of chlamydial infectivity by a nonhydrolyzable ATP analog (37). Moreover, it is notable that during the maturation of Sindbis virus into infectious particles, the Hsp70 paralogue BiP is required for proper formation of disulfide bonds within Sindbis virus membrane glycoprotein E1 (32); likewise, BiP prevents the formation of improper disulfide cross-links in influenza virus hemagglutinin (45). Thus, there is a precedent for the hypothesis that Hsp70s mediate conformational requirements for crucial functional roles, such as infectivity, in other pathogens that are encased by envelopes containing highly disulfide-cross-linked proteins.
Because our study was based on only three representative Hsp70 peptide regions, it is possible that other epitopes of Hsp70 are accessible at the EB surface. However, given the data presented here, one might consider the possibility that EB surface labeling by chlamydial Hsp70 antibodies reflects localized areas on the outer membrane where disulfide-cross-linked proteins are reduced and Hsp70 is transiently exposed. Neutralizing Hsp70 antibodies may actually interfere with entry rather than with the initial attachment of EB to a host cell.
|
|
|---|
This work was supported by Public Health Service grant AI13446.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»